Weight loss drug 'increases depression risk'

Advice to assess obese patients for depression before being given weight loss drug rimonabant has been reiterated following further evidence that the drug increases the risk of depression and anxiety.

It follows the findings of a meta-analysis of four trials carried out by Danish researchers that showed patients given rimonabant were 2.5 times more likely to stop treatment because of depression than those on placebo.

Patients were also three times more likely to quit treatment because of anxiety.

The four trials included a total of 4,105 patients who were randomly assigned 20mg rimonabant daily or placebo. Any patients suffering from depressed mood at baseline were excluded from the trial.

Patients given the drug had 4.7kg greater weight loss after the first year than those on placebo.

However, the rate of serious adverse events was 40 per cent higher in the treatment group.

In July this year, the EMEA said rimonabant should be contraindicated in those with major depression or those on antidepressants.

Dr David Haslam, clinical director of the National Obesity Forum, said GPs need to consider these contraindications before prescribing rimonabant.

A spokeswoman for manufacturer Sanofi-Aventis said it ‘has actively sought to ensure that treatment is prescribed to the right patient’.

rachel.liddle@haymarket.com


www.thelancet.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS Employers updates guidance for assessing COVID-19 risk in BAME staff

NHS Employers updates guidance for assessing COVID-19 risk in BAME staff

Updated guidance to help GP practices assess and mitigate the risk staff from black,...

PHE unable to confirm it will meet deadline for COVID-19 risk report

PHE unable to confirm it will meet deadline for COVID-19 risk report

Public Health England (PHE) has been unable to confirm if its report into how factors...

More than half of GP locums have seen a significant drop in income due to COVID-19

More than half of GP locums have seen a significant drop in income due to COVID-19

More than half of GP locums have experienced a significant fall in their income during...

How a GP helped develop a protective shield to cover patients needing CPR in the pandemic

How a GP helped develop a protective shield to cover patients needing CPR in the pandemic

Wiltshire GP Dr Lydia Campbell-Hill explains how she helped create a mini isolation...

GP practices can now sign up to new online PPE portal

GP practices can now sign up to new online PPE portal

GP practices will be able to register with the DHSC's new online PPE portal, which...

Fully-qualified GP workforce fell by 712 over the past year

Fully-qualified GP workforce fell by 712 over the past year

The fully-qualified GP workforce in England fell by 2.5%, losing 712 full-time equivalent...